These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
243 related items for PubMed ID: 27697595
1. Impact of feed counterion addition and cyclone type on aerodynamic behavior of alginic-atenolol microparticles produced by spray drying. Ceschan NE, Bucalá V, Ramírez-Rigo MV, Smyth HD. Eur J Pharm Biopharm; 2016 Dec; 109():72-80. PubMed ID: 27697595 [Abstract] [Full Text] [Related]
2. New alginic acid-atenolol microparticles for inhalatory drug targeting. Ceschan NE, Bucalá V, Ramírez-Rigo MV. Mater Sci Eng C Mater Biol Appl; 2014 Aug 01; 41():255-66. PubMed ID: 24907759 [Abstract] [Full Text] [Related]
4. Preparation and characterization of spray-dried powders intended for pulmonary delivery of insulin with regard to the selection of excipients. Razavi Rohani SS, Abnous K, Tafaghodi M. Int J Pharm; 2014 Apr 25; 465(1-2):464-78. PubMed ID: 24560646 [Abstract] [Full Text] [Related]
5. Physicochemical stability and aerosolization performance of dry powder inhalation system containing ciprofloxacin hydrochloride. Karimi K, Katona G, Csóka I, Ambrus R. J Pharm Biomed Anal; 2018 Jan 30; 148():73-79. PubMed ID: 28965047 [Abstract] [Full Text] [Related]
6. Development of a novel dry powder inhalation formulation for the delivery of rivastigmine hydrogen tartrate. Simon A, Amaro MI, Cabral LM, Healy AM, de Sousa VP. Int J Pharm; 2016 Mar 30; 501(1-2):124-38. PubMed ID: 26836711 [Abstract] [Full Text] [Related]
7. Nanospray technology for an in situ gelling nanoparticulate powder as a wound dressing. De Cicco F, Porta A, Sansone F, Aquino RP, Del Gaudio P. Int J Pharm; 2014 Oct 01; 473(1-2):30-7. PubMed ID: 24979533 [Abstract] [Full Text] [Related]
8. Design and physicochemical characterization of advanced spray-dried tacrolimus multifunctional particles for inhalation. Wu X, Hayes D, Zwischenberger JB, Kuhn RJ, Mansour HM. Drug Des Devel Ther; 2013 Oct 01; 7():59-72. PubMed ID: 23403805 [Abstract] [Full Text] [Related]
9. Development and characterisation of metformin loaded spray dried Bora rice microspheres. Sharma HK, Mohapatra J, Nath LK. Pak J Pharm Sci; 2013 Jan 01; 26(1):17-22. PubMed ID: 23261723 [Abstract] [Full Text] [Related]
10. Design and evaluation of novel inhalable sildenafil citrate spray-dried microparticles for pulmonary arterial hypertension. Shahin HI, Vinjamuri BP, Mahmoud AA, Shamma RN, Mansour SM, Ammar HO, Ghorab MM, Chougule MB, Chablani L. J Control Release; 2019 May 28; 302():126-139. PubMed ID: 30940497 [Abstract] [Full Text] [Related]
11. L-Leucine as an excipient against moisture on in vitro aerosolization performances of highly hygroscopic spray-dried powders. Li L, Sun S, Parumasivam T, Denman JA, Gengenbach T, Tang P, Mao S, Chan HK. Eur J Pharm Biopharm; 2016 May 28; 102():132-41. PubMed ID: 26970252 [Abstract] [Full Text] [Related]
12. Redispersible liposomal-N-acetylcysteine powder for pulmonary administration: development, in vitro characterization and antioxidant activity. Ourique AF, Chaves Pdos S, Souto GD, Pohlmann AR, Guterres SS, Beck RC. Eur J Pharm Sci; 2014 Dec 18; 65():174-82. PubMed ID: 25263567 [Abstract] [Full Text] [Related]
13. Design of spray dried insulin microparticles to bypass deposition in the extrathoracic region and maximize total lung dose. Ung KT, Rao N, Weers JG, Huang D, Chan HK. Int J Pharm; 2016 Sep 25; 511(2):1070-9. PubMed ID: 27480399 [Abstract] [Full Text] [Related]
14. Advanced therapeutic inhalation aerosols of a Nrf2 activator and RhoA/Rho kinase (ROCK) inhibitor for targeted pulmonary drug delivery in pulmonary hypertension: design, characterization, aerosolization, in vitro 2D/3D human lung cell cultures, and in vivo efficacy. Acosta MF, Muralidharan P, Grijalva CL, Abrahamson MD, Hayes D, Fineman JR, Black SM, Mansour HM. Ther Adv Respir Dis; 2021 Sep 25; 15():1753466621998245. PubMed ID: 33719747 [No Abstract] [Full Text] [Related]
15. Dry powder inhaler of colistimethate sodium for lung infections in cystic fibrosis: optimization of powder construction. Kozáková J, Altay A, Ždímal V, Mašková L, Sonvico F, Quarta E, Rossi A, Buttini F, Colombo G. Drug Dev Ind Pharm; 2019 Oct 25; 45(10):1664-1673. PubMed ID: 31389270 [Abstract] [Full Text] [Related]
16. The influence of storage relative humidity on aerosolization of co-spray dried powders of hygroscopic kanamycin with the hydrophobic drug rifampicin. Momin MAM, Tucker IG, Das SC. Drug Dev Ind Pharm; 2019 Jul 25; 45(7):1205-1213. PubMed ID: 30990097 [Abstract] [Full Text] [Related]
17. Development and Evaluation of Chitosan Microparticles Based Dry Powder Inhalation Formulations of Rifampicin and Rifabutin. Pai RV, Jain RR, Bannalikar AS, Menon MD. J Aerosol Med Pulm Drug Deliv; 2016 Apr 25; 29(2):179-95. PubMed ID: 26406162 [Abstract] [Full Text] [Related]
18. Conception, preparation and properties of functional carrier particles for pulmonary drug delivery. Odziomek M, Sosnowski TR, Gradoń L. Int J Pharm; 2012 Aug 20; 433(1-2):51-9. PubMed ID: 22580211 [Abstract] [Full Text] [Related]
19. Phospholipid-based pyrazinamide spray-dried inhalable powders for treating tuberculosis. Eedara BB, Tucker IG, Das SC. Int J Pharm; 2016 Jun 15; 506(1-2):174-83. PubMed ID: 27091294 [Abstract] [Full Text] [Related]
20. Porous and highly dispersible voriconazole dry powders produced by spray freeze drying for pulmonary delivery with efficient lung deposition. Liao Q, Yip L, Chow MYT, Chow SF, Chan HK, Kwok PCL, Lam JKW. Int J Pharm; 2019 Apr 05; 560():144-154. PubMed ID: 30731259 [Abstract] [Full Text] [Related] Page: [Next] [New Search]